Myoderm has expanded its portfolio to include distribution management services in an effort to provide clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials. According to the company, its distribution management service is an alternative to the current approach to site or patient reimbursement of commercially sourced drugs, and is designed to lower costs. The newly constructed distribution facilities features customize...